Cargando…

Impact of Omicron surge in community setting in greater Paris area

INTRODUCTION: The SARS-CoV-2 Omicron variant of concern (VOC) was first identified in South Africa during November 2021, and has now become the dominant variant in Europe and worldwide. However, as the number of Omicron COVID-19 cases increased rapidly in South Africa, the rate of hospitalization du...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinh, A., Dahmane, L., Dahoumane, M., Duran, C., Masingue, X., Jourdain, P., Lescure, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152517/
http://dx.doi.org/10.1016/j.mmifmc.2022.03.066
_version_ 1784717668459216896
author Dinh, A.
Dahmane, L.
Dahoumane, M.
Duran, C.
Masingue, X.
Jourdain, P.
Lescure, X.
author_facet Dinh, A.
Dahmane, L.
Dahoumane, M.
Duran, C.
Masingue, X.
Jourdain, P.
Lescure, X.
author_sort Dinh, A.
collection PubMed
description INTRODUCTION: The SARS-CoV-2 Omicron variant of concern (VOC) was first identified in South Africa during November 2021, and has now become the dominant variant in Europe and worldwide. However, as the number of Omicron COVID-19 cases increased rapidly in South Africa, the rate of hospitalization due to Omicron infections seemed lower than that of Delta infections. The Greater Paris area has experienced five COVID-19 surges. We aimed to assess the impact and clinical severity of patients infected during the Omicron surge compared with the previous surges in community setting in this area. MATÉRIELS ET MÉTHODES: We performed a cohort study including adult patients, with confirmed COVID-19 diagnosis (RT-PCR or antigen), managed from 9 March 2020 until 11 January 2022 with Covidom, a telesurveillance solution for home monitoring of patients with COVID-19 in the greater Paris area. When included, the patients completed on a daily basis self-administered questionnaires until 10 to 30 days according to symptom course. According to predefined thresholds, questionnaires could generate 2 types of alerts: orange alert (mild priority), and red alert (top priority alert). Outcome was recorded: unplanned hospitalization (including in intensive care unit), contact with national emergency number, or admission to Emergency department. RÉSULTATS: Overall, 225,248 patients were included in the study, including 72,394 from the last surge, which is more numerous compared to the previous surges. Patients included during the Delta and Omicron waves were younger (mean age 35.6 ± 13.0 and 38.4 ± 13.0 versus maximum 44.5 ± 14.5 years in surge 1; p<0.001). Significantly fewer patients with comorbidities were included in surge 5 (p<0.001), and the proportion presenting with respiratory signs was lower (49.8% in surge 5 vs maximum 86.5% in surge 1; p<0.001). During surge 5, while the number of patients included was high compared to previous surges, the rate of orange and red alerts was significantly lower (p<0.0001), as the number of hospitalizations, national emergency contact and emergency unit requirement (p<0.0001). CONCLUSION: These data confirm that the Omicron surge is highly significant considering the number of cases but presents with a low rate of severe presentation and worsening. Aucun lien d'intérêt
format Online
Article
Text
id pubmed-9152517
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Masson SAS
record_format MEDLINE/PubMed
spelling pubmed-91525172022-05-31 Impact of Omicron surge in community setting in greater Paris area Dinh, A. Dahmane, L. Dahoumane, M. Duran, C. Masingue, X. Jourdain, P. Lescure, X. Médecine et Maladies Infectieuses Formation Col08-05 INTRODUCTION: The SARS-CoV-2 Omicron variant of concern (VOC) was first identified in South Africa during November 2021, and has now become the dominant variant in Europe and worldwide. However, as the number of Omicron COVID-19 cases increased rapidly in South Africa, the rate of hospitalization due to Omicron infections seemed lower than that of Delta infections. The Greater Paris area has experienced five COVID-19 surges. We aimed to assess the impact and clinical severity of patients infected during the Omicron surge compared with the previous surges in community setting in this area. MATÉRIELS ET MÉTHODES: We performed a cohort study including adult patients, with confirmed COVID-19 diagnosis (RT-PCR or antigen), managed from 9 March 2020 until 11 January 2022 with Covidom, a telesurveillance solution for home monitoring of patients with COVID-19 in the greater Paris area. When included, the patients completed on a daily basis self-administered questionnaires until 10 to 30 days according to symptom course. According to predefined thresholds, questionnaires could generate 2 types of alerts: orange alert (mild priority), and red alert (top priority alert). Outcome was recorded: unplanned hospitalization (including in intensive care unit), contact with national emergency number, or admission to Emergency department. RÉSULTATS: Overall, 225,248 patients were included in the study, including 72,394 from the last surge, which is more numerous compared to the previous surges. Patients included during the Delta and Omicron waves were younger (mean age 35.6 ± 13.0 and 38.4 ± 13.0 versus maximum 44.5 ± 14.5 years in surge 1; p<0.001). Significantly fewer patients with comorbidities were included in surge 5 (p<0.001), and the proportion presenting with respiratory signs was lower (49.8% in surge 5 vs maximum 86.5% in surge 1; p<0.001). During surge 5, while the number of patients included was high compared to previous surges, the rate of orange and red alerts was significantly lower (p<0.0001), as the number of hospitalizations, national emergency contact and emergency unit requirement (p<0.0001). CONCLUSION: These data confirm that the Omicron surge is highly significant considering the number of cases but presents with a low rate of severe presentation and worsening. Aucun lien d'intérêt Published by Elsevier Masson SAS 2022-06 2022-05-31 /pmc/articles/PMC9152517/ http://dx.doi.org/10.1016/j.mmifmc.2022.03.066 Text en Copyright © 2022 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Col08-05
Dinh, A.
Dahmane, L.
Dahoumane, M.
Duran, C.
Masingue, X.
Jourdain, P.
Lescure, X.
Impact of Omicron surge in community setting in greater Paris area
title Impact of Omicron surge in community setting in greater Paris area
title_full Impact of Omicron surge in community setting in greater Paris area
title_fullStr Impact of Omicron surge in community setting in greater Paris area
title_full_unstemmed Impact of Omicron surge in community setting in greater Paris area
title_short Impact of Omicron surge in community setting in greater Paris area
title_sort impact of omicron surge in community setting in greater paris area
topic Col08-05
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152517/
http://dx.doi.org/10.1016/j.mmifmc.2022.03.066
work_keys_str_mv AT dinha impactofomicronsurgeincommunitysettingingreaterparisarea
AT dahmanel impactofomicronsurgeincommunitysettingingreaterparisarea
AT dahoumanem impactofomicronsurgeincommunitysettingingreaterparisarea
AT duranc impactofomicronsurgeincommunitysettingingreaterparisarea
AT masinguex impactofomicronsurgeincommunitysettingingreaterparisarea
AT jourdainp impactofomicronsurgeincommunitysettingingreaterparisarea
AT lescurex impactofomicronsurgeincommunitysettingingreaterparisarea